Open AccessChoosing the Appropriate Target for the Treatment of Psoriatic Arthritis: TNFα, IL-17, IL-23 or JAK Inhibitors?
Author(s) -
Chrysoula G Gialouri,
Gerasimos Evangelatos,
G. Fragoulis
Publication year - 2022
Publication title -
mediterranean journal of rheumatology
Language(s) - English
Resource type - Journals
ISSN - 2529-198X
DOI - 10.31138/mjr.33.1.150
Subject(s) - medicine , dactylitis , etanercept , psoriatic arthritis , psoriasis , enthesitis , disease , inflammatory bowel disease , adverse effect , arthritis , rheumatoid arthritis , immunology , dermatology